Trial Details

Recruiting
Basic Information
Clinical ID c5030
Identifier IRCT20230511058153N1
Trial Title Comparison of the combined effect of mesalazine-crocin with mesalazine alone in the treatment of inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Condition 1: Crohn's disease. Condition 2: Ulcerative colitis. Crohn's disease [regional enteritis] Ulcerative colitis
Interventions Intervention 1: Intervention group: Standard treatment (Mesalazine tablet 1000 mg 3 times a day, Kimidaro Pharmaceutical Company) plus crocin capsule 15 mg (Darumed Pharmaceutical Company) twice a day for 8 weeks. Intervention 2: Control group: Standard t
Participant Information
Sponsor Shahre-kord University of Medical Sciences
City NULL
Country/Region Iran
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL